Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
27.25
-0.54 (-1.94%)
At close: Mar 18, 2026, 4:00 PM EDT
27.24
-0.01 (-0.04%)
Pre-market: Mar 19, 2026, 6:21 AM EDT
Enliven Therapeutics Market Cap
Enliven Therapeutics has a market cap or net worth of $1.63 billion as of March 19, 2026. Its market cap has increased by 69.99% in one year.
Market Cap
1.63B
Enterprise Value
1.17B
1-Year Change
69.99%
Ranking
Category
Stock Price
$27.25
Market Cap Chart
Since February 24, 2023, Enliven Therapeutics's market cap has increased from $974.02M to $1.63B, an increase of 67.30%. That is a compound annual growth rate of 18.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 17, 2026 | 1.66B | 81.83% |
| Dec 31, 2025 | 913.95M | -16.86% |
| Dec 31, 2024 | 1.10B | 92.74% |
| Dec 29, 2023 | 570.37M | -41.44% |
| Feb 24, 2023 | 974.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Soleno Therapeutics | 1.74B |
| Novavax | 1.73B |
| Agios Pharmaceuticals | 1.69B |
| Vericel | 1.65B |
| Harmony Biosciences Holdings | 1.64B |
| Innoviva | 1.63B |
| Sionna Therapeutics | 1.61B |
| Iovance Biotherapeutics | 1.60B |